🇺🇸 FDA
Pipeline program

ZASOCITINIB, ZASOCITINIB, White opaque, hard hypromellose capsule, size 3 containing same excipients as TAK-279 active capsule

TAK-279-VT-2001

Phase 2 small_molecule active

Quick answer

ZASOCITINIB, ZASOCITINIB, White opaque, hard hypromellose capsule, size 3 containing same excipients as TAK-279 active capsule for Non-segmental vitiligo is a Phase 2 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Non-segmental vitiligo
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials